Bomi Group, a leading company in the field of integrated logistics serving the Healthcare sector, announces the acquisition of Logifarma, a historic Italian company specializing in pharmaceutical logistics.
Logifarma was born in 1997 in Pomezia, 25 km from the capital, in the heart of a pharmaceutical center of excellence on a European level. To date, the company is one of the Italian reference points in the logistics of the pharmaceutical sector with more than 30 internationally recognized customers.
The 5.000 sqm warehouse is intended for the storage of products at a controlled temperature of + 15 /+ 25 ° C and + 2 /+ 8 ° C, the latter in a dedicated cell of 400 sqm. In addition to storage and distribution activities,
- primary transport services;
- in-house management for production;
- 300 sqm GMP manufacturing site where the reworking of any type of drug or food supplement takes place.
Logifarma also holds AIFA authorizations for API storage, import of medicines and packaging of experimental drugs.
Bomi thus continues its consolidation in the pharmaceutical sector, strengthening its presence in an important and strategic territory such as the Pomezia hub and offering its customers maximum flexibility in the strategic management of stocks.
“We are honored to be able to welcome Logifarma into our Group. This operation takes a new and important step towards our development in the pharmaceutical sector – comments Marco Ruini, CEO of Bomi Group – and confirms our commitment in providing customers with a service dedicated to the healthcare sector and rooted in local excellence, which are strengthened in a multinational group “.
“This operation adds another important element for the Group’s growth. We are confident that these synergies will bring great results for both” comments Stefano Camurri, Head of Southern Europe of the Bomi Group.
“We are proud to join a solid and international group like Bomi”, commented Giuseppe Paradisi, CEO of Logifarma. “With this step, Logifarma adds great development potential and broadens its future horizons”.